Columbia Partners Investment Management’s Boston Scientific BSX Stock Holding History

Columbia Partners Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-113,782	Closed	-$3.11M	–	157
2018 Q1	$3.11M	Sell	113,782 -7,684	-6%	-$209K	0.4%	72
2017 Q4	$3.01M	Sell	121,466 -8,018	-6%	-$221K	0.4%	81
2017 Q3	$3.78M	Sell	129,484 -26,680	-17%	-$737K	0.5%	60
2017 Q2	$4.33M	Sell	156,164 -13,880	-8%	-$368K	0.55%	54
2017 Q1	$4.23M	Sell	170,044 -1,642	-1%	-$39.9K	0.54%	52
2016 Q4	$3.71M	Buy	+171,686	New	+$3.75M	0.33%	108
2014 Q1	–	Sell	-86,659	Closed	-$1.04M	–	330
2013 Q4	$1.04M	Buy	86,659 +8,408	+11%	+$99.3K	0.04%	251
2013 Q3	$918K	Sell	78,251 -15,717	-17%	-$170K	0.04%	261
2013 Q2	$871K	Buy	+93,968	New	+$797K	0.04%	271

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Columbia Partners Investment Management's BSX Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Boston Scientific (BSX) in Q2 2018, closing a stake of 113,782 shares — an estimated $3.11M sold.

Columbia Partners Investment Management first reported a position in BSX in Q2 2013 and held it in 9 quarters. The position peaked at $4.33M in Q2 2017. 672 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

Columbia Partners Investment Management reported no remaining Boston Scientific position as of Q2 2018 after selling out during the quarter.
Columbia Partners Investment Management sold 113,782 Boston Scientific shares in Q2 2018, an estimated $3.11M.
Columbia Partners Investment Management first reported a position in Boston Scientific in Q2 2013 and held it in 9 quarters.
Columbia Partners Investment Management's Boston Scientific position peaked at $4.33M in Q2 2017.
672 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.